Po-cheng Liang

100 Tzyou Road, 807
Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

Predicting non-alcoholic fatty liver disease (NAFLD) using machine learning algorithms: Evidence from a large-scale community cohort in Taiwan.

Predicting non-alcoholic fatty liver disease (NAFLD) using machine learning algorithms: Evidence from a large-scale community cohort in Taiwan.

Journal: Bioscience trends

Published: March 01, 2026

Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

Journal: Journal of gastroenterology and hepatology

Published: February 06, 2026

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

Journal: The Kaohsiung journal of medical sciences

Published: January 13, 2026

Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B.

Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: December 24, 2025

Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study.

Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study.

Journal: Liver cancer

Published: November 13, 2025

Prevalence and associated factors of metabolic dysfunction-associated steatotic liver disease in Taiwan, 2001-2021.

Prevalence and associated factors of metabolic dysfunction-associated steatotic liver disease in Taiwan, 2001-2021.

Journal: Hepatology international

Published: October 07, 2025

FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.

FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.

Journal: Journal of gastroenterology and hepatology

Published: August 26, 2025

Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication.

Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication.

Journal: Alimentary pharmacology & therapeutics

Published: August 23, 2025

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine.

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine.

Journal: The Kaohsiung journal of medical sciences

Published: July 27, 2025

Nationwide hepatitis C virus microelimination in uremic patients undergoing maintenance hemodialysis in Taiwan.

Nationwide hepatitis C virus microelimination in uremic patients undergoing maintenance hemodialysis in Taiwan.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: June 05, 2025

Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B.

Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B.

Journal: Journal of gastroenterology and hepatology

Published: April 19, 2025

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD.

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD.

Journal: The Kaohsiung journal of medical sciences

Published: March 24, 2025

Showing 1-12 of 103

Last Updated: 09/26/2026